Bristol Myers, yielding to FDA pressure, pulls Opdivo in post-Nexavar liver cancer

Bristol Myers, yielding to FDA pressure, pulls Opdivo in post-Nexavar liver cancer
aliu
Mon, 07/26/2021 – 05:47